Advanced in Choledocholithiasis

Alfred Konigsrainer

Otfried Müller Str. 10, 
Tuebingen, BW, DE 
Advanced in Choledocholithiasis
Otfried Müller Str. 10, 
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Alfred Konigsrainer practices in Tuebingen, Germany. Mr. Konigsrainer is rated as an Advanced expert by MediFind in the treatment of Choledocholithiasis. His top areas of expertise are Appendicitis, Liver Failure, Esophageal Perforation, Liver Transplant, and Hepatectomy.

His clinical research consists of co-authoring 364 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Choledocholithiasis.

Gender
Male

Locations

Otfried Müller Str. 10, Tuebingen, BW 72076, Germany
Other Locations
Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany
Hoppe Seyler Str. 3-5, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase II Pilot Study to Reduce the Incidence of Peritoneal Carcinoma After Curative Gastrectomy of Gastric Carcinoma or Adenocarcinoma of Gastroesophageal Transition by Hyperthermic Intraperitoneal Chemoperfusion
Phase II Pilot Study to Reduce the Incidence of Peritoneal Carcinoma After Curative Gastrectomy of Gastric Carcinoma or Adenocarcinoma of Gastroesophageal Transition by Hyperthermic Intraperitoneal Chemoperfusion
Enrollment Status: Withdrawn
Publish Date: April 03, 2025
Intervention Type: Drug
Study Drug: Intraoperative hyperthermic intraperitoneal chemotherapy
Study Phase: Phase 2
A Phase I/II Trial of IMA970A Plus CV8102 Following a Single Pre-vaccination Infusion of Cyclophosphamide in Patients With Very Early, Early and Intermediate Stage of Hepatocellular Carcinoma After Any Standard Treatments
A Phase I/II Trial of IMA970A Plus CV8102 Following a Single Pre-vaccination Infusion of Cyclophosphamide in Patients With Very Early, Early and Intermediate Stage of Hepatocellular Carcinoma After Any Standard Treatments
Enrollment Status: Completed
Publish Date: February 05, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer
Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer
Enrollment Status: Terminated
Publish Date: January 30, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

364 Total Publications

Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case.
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case.
Journal: Journal for immunotherapy of cancer
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Konigsrainer's expertise for a condition
ConditionClose
    View All 25 Advanced Conditions
    View All 66 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile